Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14623342rdf:typepubmed:Citationlld:pubmed
pubmed-article:14623342lifeskim:mentionsumls-concept:C0281361lld:lifeskim
pubmed-article:14623342lifeskim:mentionsumls-concept:C0059239lld:lifeskim
pubmed-article:14623342lifeskim:mentionsumls-concept:C1565434lld:lifeskim
pubmed-article:14623342lifeskim:mentionsumls-concept:C2347610lld:lifeskim
pubmed-article:14623342lifeskim:mentionsumls-concept:C0045093lld:lifeskim
pubmed-article:14623342lifeskim:mentionsumls-concept:C1136031lld:lifeskim
pubmed-article:14623342lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:14623342lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:14623342pubmed:issue3lld:pubmed
pubmed-article:14623342pubmed:dateCreated2003-11-18lld:pubmed
pubmed-article:14623342pubmed:abstractTextFocal adhesion kinase (FAK) is an important regulator of cellular signaling, migration, apoptosis, and cell cycle progression. We tested the hypothesis that FAK is a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells and examined the effect of inhibiting FAK expression on gemcitabine-induced cytotoxicity in vitro and in vivo. FAK expression was quantified by Western and Northern blots. Expression of FAK was suppressed using small interfering RNA (siRNA). Gemcitabine-induced cytotoxicity was quantified and apoptosis was characterized. Akt activity was determined by in vitro kinase assay. We assessed the therapeutic applicability of FAK siRNA in a nude mouse orthotopic xenograft model. While not affecting cellular proliferation or apoptosis in the absence of gemcitabine, FAK siRNA potentiated gemcitabine-induced cytotoxicity in vitro and in vivo. FAK siRNA treatment suppressed Akt activity, which may contribute to its chemosensitizing effect.lld:pubmed
pubmed-article:14623342pubmed:languageenglld:pubmed
pubmed-article:14623342pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:citationSubsetIMlld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14623342pubmed:statusMEDLINElld:pubmed
pubmed-article:14623342pubmed:monthNovlld:pubmed
pubmed-article:14623342pubmed:issn0006-291Xlld:pubmed
pubmed-article:14623342pubmed:authorpubmed-author:AshleyStanley...lld:pubmed
pubmed-article:14623342pubmed:authorpubmed-author:ZinnerMichael...lld:pubmed
pubmed-article:14623342pubmed:authorpubmed-author:WhangEdward...lld:pubmed
pubmed-article:14623342pubmed:authorpubmed-author:ItoHiromichiHlld:pubmed
pubmed-article:14623342pubmed:authorpubmed-author:DuxburyMark...lld:pubmed
pubmed-article:14623342pubmed:authorpubmed-author:BenoitEricElld:pubmed
pubmed-article:14623342pubmed:issnTypePrintlld:pubmed
pubmed-article:14623342pubmed:day21lld:pubmed
pubmed-article:14623342pubmed:volume311lld:pubmed
pubmed-article:14623342pubmed:ownerNLMlld:pubmed
pubmed-article:14623342pubmed:authorsCompleteYlld:pubmed
pubmed-article:14623342pubmed:pagination786-92lld:pubmed
pubmed-article:14623342pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:meshHeadingpubmed-meshheading:14623342...lld:pubmed
pubmed-article:14623342pubmed:year2003lld:pubmed
pubmed-article:14623342pubmed:articleTitleRNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity.lld:pubmed
pubmed-article:14623342pubmed:affiliationDepartment of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.lld:pubmed
pubmed-article:14623342pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14623342pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14623342lld:pubmed